Core Insights - Robertet has expanded its partnership with Aethera Biotech through a strategic investment, marking a significant step into biotechnology and reinforcing its commitment to innovative solutions that blend nature with technology [1][2][6] Company Overview - Robertet, founded in 1850, is a global leader in natural products, operating in over 50 countries with more than 2,500 employees and generating net global revenue exceeding €807 million in 2024 [9] - Aethera Biotech, established in 2016, specializes in the research and production of active ingredients from cell multiplication processes, primarily for the cosmetics and health markets [3][10] Strategic Partnership - The joint venture between Robertet and Aethera Biotech aims to create synergies by combining Aethera's advanced platform and production capabilities with Robertet's global reach and commercial expertise [2][5] - This partnership will enable Robertet to enter the market for topical cosmetic active ingredients and strengthen its biotechnology expertise [7][8] Technological Innovation - Aethera Biotech's proprietary CROP® technology allows for the secure production of natural extracts in controlled conditions, significantly reducing environmental impact and offering a sustainable alternative to traditional methods [4][6] - The collaboration is expected to accelerate innovation in skin science, aligning with Robertet's "Augmented Naturality" strategy [8] Future Growth Potential - The investment will be completed in two phases over a three-year period, supporting long-term growth by commercializing Aethera's portfolio through Robertet's global distribution network [5][7] - The partnership is anticipated to enhance Robertet's position in the cosmetic active ingredients market and boost long-term growth through a unique range of products [6][8]